Chronic kidney disease (CKD) is a widespread and often silent condition affecting approximately 37 million American adults, or nearly one in seven, according to the Centers for Disease Control and Prevention (CDC). Despite contributing to at least 38,000 deaths each year—a figure exceeding fatalities from melanoma, brain, and prostate cancers combined—the vast majority of individuals with CKD remain unaware of their diagnosis.
Dr. Philippa Kaye, a primary care physician, author, and broadcaster, highlights that CKD often presents no discernible symptoms in its early stages, as the body can compensate for a decline in kidney function. This lack of outward signs means that cases are frequently discovered incidentally through routine blood or urine tests performed for other health concerns. When symptoms do emerge, they are typically vague, such as fatigue, brain fog, or itchy skin. Later-stage indicators can include weight loss, swelling in the extremities, breathlessness, blood in urine, increased urination frequency, or muscle cramps.
The primary danger associated with CKD, even in mild forms, lies in the increased strain it places on the heart and blood vessels. Individuals with CKD are approximately 20 times more likely to succumb to a heart attack or stroke than to reach kidney failure.
CKD is closely linked to diabetes and high blood pressure, with a bidirectional relationship: these conditions can damage the kidneys, and impaired kidney function can, in turn, elevate blood sugar levels and blood pressure. Lifestyle factors such as an unhealthy diet, lack of exercise, excessive alcohol consumption, and smoking are significant contributors to the development of both diabetes and high blood pressure.
Diagnosis typically relies on two simple tests administered by primary care physicians: a blood test to measure creatinine levels, indicating kidney filtration efficiency, and a urine test to detect albumin, a protein that signifies kidney damage. Kaye urges individuals with diabetes or high blood pressure to proactively request these tests.
While CKD cannot be reversed, early diagnosis is crucial for halting its progression. Management strategies focus on controlling blood pressure and diabetes through weight loss, a balanced diet rich in fruits, vegetables, and whole grains, and reduced intake of salt and sugar. Maintaining an active lifestyle is also vital for cardiovascular health.
Recent medical advancements have introduced a class of drugs known as SGLT2 inhibitors, including dapagliflozin and empagliflozin. Originally developed for diabetes treatment, these medications have demonstrated in clinical trials the ability to significantly slow the decline of kidney function and reduce the risk of heart failure and mortality in CKD patients, irrespective of their diabetes status. Patients diagnosed with CKD who have not been considered for these treatments are advised to consult their doctors.
Kaye emphasizes the importance of regular health screenings, particularly for individuals aged 40 to 74. Standard health checks, which include blood pressure, blood glucose, and cholesterol monitoring, can also assess kidney function if elevated blood pressure is detected. She encourages proactive engagement with healthcare providers to prevent severe outcomes associated with undetected CKD.